The company plans to integrate GridGain’s in-memory computing tech to deliver sub-millisecond performance for operational, transactional, and AI applications.

The U.S. presented new seismic data Tuesday to buttress its recent allegation that China has secretly carried out low-yield nuclear tests, challenging Beijing’s insistence that it has scrupulously ...

Start │ ├─ [Step 0] test_only mode? │ ├─ Yes → Test MySQL & PostgreSQL connections → Show versions → Exit │ └─ No → Continue │ ├─ [Step 1] Read MySQL table definitions │ ├─ If ...

Roughly 80% of enterprise data sits in emails, contracts, call transcripts, and PDFs where traditional databases can't touch it. Much of this "unstructured" data isn't ignored because it lacks value, ...

OpenAI’s massive data center plan, called Stargate, in Saline Township is what it says it is — hyperscale. The initial $7 billion buildout is on a scale the state has never seen. Other OpenAI/Oracle ...

There is good and bad news in this year’s newly released standardized test scores for New Jersey public school students. The good news is the average test scores on the science portion of the tests ...

Dr. Twenge is a psychology professor at San Diego State University and the author of “10 Rules for Raising Kids in a High-Tech World.” The standardized test scores of American students had been rising ...

When running a Meta Ads campaign, creative should be at the center of your strategy. As targeting options have become more limited in the platform from the super-granular segments available in years ...

Amid mounting financial and operational pressures, healthcare leaders are turning to AI not only to optimize revenue cycle performance but to reimagine it entirely. During a recent discussion at ...

What it takes to deliver on data and AI strategy. In partnership withDatabricks Four years is a lifetime when it comes to artificial intelligence. Since the first edition of this study was published ...

Grail is on a mission to have its cancer blood test become a core part of U.S. screening for a range of tumors. Now, it’s detailing its latest data as it heads to the FDA. Back in June, Grail revealed ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. As part of its bid to transform the future of cancer screening and seize control of ...